These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29157801)

  • 21. Corrigendum to "Formulation and stabilization of norfloxacin in liposomal preparations" [Eur. J. Pharm. Sci. 91 (2016) 208-215].
    Ahmad I; Arsalan A; Ali SA; Bano R; Munir I; Sabah A
    Eur J Pharm Sci; 2016 Oct; 93():507. PubMed ID: 27659781
    [No Abstract]   [Full Text] [Related]  

  • 22. NMR structure of biosynthetic engineered human insulin monomer B31(Lys)-B32(Arg) in water/acetonitrile solution. Comparison with the solution structure of native human insulin monomer.
    Bocian W; Borowicz P; Mikołajczyk J; Sitkowski J; Tarnowska A; Bednarek E; Głabski T; Tejchman-Małecka B; Bogiel M; Kozerski L
    Biopolymers; 2008 Oct; 89(10):820-30. PubMed ID: 18491415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum to "Topical delivery of aqueous micellar Resolvin E1 analog (RX-10045)" [Int. J. Pharm. 498 (2016) 326-334].
    Cholkar K; Gilger BC; Mitra AK
    Int J Pharm; 2016 Jul; 509(1-2):528. PubMed ID: 27350413
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine" [Int. J. Pharm. 502 (1-2) (2016) 151-160].
    Tran T; Xi X; Rades T; Müllertz A
    Int J Pharm; 2016 Jun; 507(1-2):109. PubMed ID: 27241782
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis" [Int. J. Pharm. 535 (2018) 113-119].
    Williams AJ; Jordan F; King G; Lewis AL; Illum L; Masud T; Perkins AC; Pearson RG
    Int J Pharm; 2018 Aug; 547(1-2):667. PubMed ID: 29983223
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line" [Eur. J. Pharm. Biopharm. 119 (2017) 253-263].
    Guccione C; Oufir M; Piazzini V; Eigenmann DE; Jähne EA; Zabela V; Faleschini MT; Bergonzi MC; Smiesko M; Hamburger M; Bilia AR
    Eur J Pharm Biopharm; 2017 Nov; 120():146. PubMed ID: 28941379
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "Triboelectrification: A review of experimental and mechanistic modeling approaches with a special focus on pharmaceutical powders" [Int. J. Pharm. 510 (2016) 375-385].
    Naik S; Mukherjee R; Chaudhuri B
    Int J Pharm; 2016 Oct; 512(1):329. PubMed ID: 27646923
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "Development of silymarin topical formulation: In vitro and ex vivo dermal kinetics of silymarin" [Int. J. Pharm. 63 (2023) 122431].
    Shankar VK; Police A; Ajjarapu S; Murthy SN
    Int J Pharm; 2023 Mar; 635():122590. PubMed ID: 36890040
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of spectral integration and normalization in NMR-based metabonomic analyses.
    Webb-Robertson BJ; Lowry DF; Jarman KH; Harbo SJ; Meng QR; Fuciarelli AF; Pounds JG; Lee KM
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):830-6. PubMed ID: 15990265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC/MS fingerprinting of Shenmai injection: a novel approach to quality control of herbal medicines.
    Xiaohui F; Yi W; Yiyu C
    J Pharm Biomed Anal; 2006 Feb; 40(3):591-7. PubMed ID: 16356676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural meta-analysis of regular human insulin in pharmaceutical formulations.
    Fávero-Retto MP; Palmieri LC; Souza TA; Almeida FC; Lima LM
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1112-21. PubMed ID: 23692694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation.
    Gast K; Schüler A; Wolff M; Thalhammer A; Berchtold H; Nagel N; Lenherr G; Hauck G; Seckler R
    Pharm Res; 2017 Nov; 34(11):2270-2286. PubMed ID: 28762200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of saponins in Maesa lanceolata by LC-UV: development and validation.
    Theunis MH; Foubert K; Pollier J; Gonzalez-Guzman M; Goossens A; Vlietinck AJ; Pieters LA; Apers S
    Phytochemistry; 2007; 68(22-24):2825-30. PubMed ID: 17981308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a long-acting insulin analog using albumin fusion technology.
    Duttaroy A; Kanakaraj P; Osborn BL; Schneider H; Pickeral OK; Chen C; Zhang G; Kaithamana S; Singh M; Schulingkamp R; Crossan D; Bock J; Kaufman TE; Reavey P; Carey-Barber M; Krishnan SR; Garcia A; Murphy K; Siskind JK; McLean MA; Cheng S; Ruben S; Birse CE; Blondel O
    Diabetes; 2005 Jan; 54(1):251-8. PubMed ID: 15616036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of methods for predicting dissolution and the theoretical implications of particle-size-dependent solubility.
    Johnson KC
    J Pharm Sci; 2012 Feb; 101(2):681-9. PubMed ID: 21989679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs).
    Elder DP; Lipczynski AM; Teasdale A
    J Pharm Biomed Anal; 2008 Nov; 48(3):497-507. PubMed ID: 18657926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of clinical trials: update on oral insulin spray formulation.
    Pozzilli P; Raskin P; Parkin CG
    Diabetes Obes Metab; 2010 Feb; 12(2):91-6. PubMed ID: 19889002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled insulin: Exubera.
    Odegard PS; Capoccia KL
    Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum to "Functional electrospun fibers for the treatment of human skin wounds" [Eur. J. Pharm. Biopharm. 119 (2017) 283-299].
    Wang J; Windbergs M
    Eur J Pharm Biopharm; 2018 Nov; 132():93. PubMed ID: 30314750
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules.
    Cournarie F; Chéron M; Besnard M; Vauthier C
    Eur J Pharm Biopharm; 2004 Mar; 57(2):171-9. PubMed ID: 15018972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.